V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158993 | 20060979 | 1.7 | 88 | Palliative (P) | 2018-10-28 | 2018-11-03 | ECX | 02 | N | ECX | 101175448 |
| 20158996 | 20060980 | null | null | Curative (C) | 2019-11-19 | 2019-11-21 | ECX | 2 | null | ECX | 101301547 |
| 20159000 | 20060981 | 1.68 | 73 | Palliative (P) | 2016-12-22 | 2017-01-02 | ECX | N | N | ECX | 101717112 |
| 20159001 | 20060982 | null | null | Adjuvant (A) | 2016-11-23 | 2016-11-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100732452 |
| 20159006 | 20060983 | 1.72 | 77 | Palliative (P) | 2018-02-15 | 2018-03-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101298402 |
| 20159008 | 20060984 | 1.61 | 53.3 | Not known (9) | 2019-07-13 | 2019-07-19 | ECX | N | N | ECX | 101715989 |
| 20159011 | 20060985 | 1.62 | 81 | null | 2016-05-04 | 2016-05-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101236213 |
| 20159012 | 20060986 | 1.85 | 55 | Curative (C) | 2017-11-02 | 2017-11-14 | ECX | N | N | ECX | 101227575 |
| 20159013 | 20060987 | 1.59 | 75.9 | null | 2017-02-09 | 2017-02-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100100016 |
| 20159014 | 20060988 | 1.65 | 58.6 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-23 | ECX | 02 | N | ECX | 100066974 |
| 20159015 | 20060989 | 1.78 | 51 | Adjuvant (A) | 2016-03-20 | 2016-04-09 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100441515 |
| 20159018 | 20060990 | 1.52 | 58.8 | Adjuvant (A) | 2019-11-01 | 2019-11-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100224692 |
| 20159019 | 20060991 | 1.7 | 87.8 | Palliative (P) | 2016-06-03 | 2016-06-03 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101436270 |
| 20159020 | 20060992 | 1.64 | 55.65 | Neo-adjuvant (N) | 2019-09-25 | 2019-10-08 | ECX | N | N | ECX | 100681808 |
| 20159026 | 20060993 | 1.7 | 77.2 | Neo-adjuvant (N) | 2016-03-26 | 2016-04-13 | ECX | N | N | ECX | 100696032 |
| 20159031 | 20060994 | null | null | Adjuvant (A) | 2019-05-26 | 2019-06-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100644648 |
| 20159033 | 20060995 | 1.72 | 62.3 | Palliative (P) | 2017-08-28 | 2017-09-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100454913 |
| 20159034 | 20060996 | 1.64 | 99 | Palliative (P) | 2017-09-20 | 2017-10-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100964552 |
| 20159035 | 20060997 | 1.82 | 50.7 | Adjuvant (A) | 2017-02-26 | 2017-02-28 | ECX | 02 | N | ECX | 100064559 |
| 20159036 | 20060998 | 1.61 | 69.2 | Curative (C) | 2016-08-18 | 2016-09-28 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101232494 |
| 20159037 | 20060999 | 1.56 | 105.4 | Palliative (P) | 2019-02-18 | 2019-02-18 | ECX | 02 | N | ECX | 101387231 |
| 20159039 | 20061000 | 1.67 | 90 | Palliative (P) | 2016-10-07 | 2016-10-24 | ECX | N | N | ECX | 100044068 |
| 20159042 | 20061001 | 1.59 | 62.1 | Neo-adjuvant (N) | 2019-04-26 | 2019-05-10 | ECX | N | N | ECX | 101392941 |
| 20159043 | 20061002 | 1.7 | 64.3 | Adjuvant (A) | 2020-08-26 | 2020-09-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101105691 |
| 20159044 | 20061003 | 1.68 | 46.2 | Palliative (P) | 2019-08-05 | 2019-08-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100419916 |
| 20159045 | 20061004 | 1.8 | 91.4 | Adjuvant (A) | 2016-05-20 | 2016-05-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101603017 |
| 20159046 | 20061005 | 1.64 | 59 | Neo-adjuvant (N) | 2019-02-12 | 2019-02-12 | ECX | 02 | N | ECX | 101632149 |
| 20159047 | 20061006 | 1.5 | 55.9 | Neo-adjuvant (N) | 2017-01-14 | 2017-01-23 | ECX | N | N | ECX | 101223124 |
| 20159049 | 20061007 | 1.79 | 61 | Neo-adjuvant (N) | 2017-08-06 | 2017-08-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100576589 |
| 20159051 | 20061008 | 1.58 | 86.7 | null | 2018-02-06 | 2018-02-11 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100505182 |
| 20159052 | 20061009 | 1.61 | 56.5 | Palliative (P) | 2019-12-04 | 2019-12-07 | ECX | 02 | N | ECX | 101566757 |
| 20159054 | 20061010 | 1.75 | 53.9 | null | null | 2017-01-02 | Gemcitabine + Capecitabine | null | N | ECX | 101867641 |
| 20159056 | 20061011 | 1.64 | 64.2 | Adjuvant (A) | 2017-08-25 | 2017-08-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100121029 |
| 20159057 | 20061012 | 1.79 | 74.2 | Neo-adjuvant (N) | 2017-12-14 | 2018-01-01 | ECX | N | N | ECX | 101000173 |
| 20159058 | 20061013 | 1.49 | 118.2 | Curative (C) | 2018-02-22 | 2018-03-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100165803 |
| 20159059 | 20061014 | 1.84 | 57.3 | Palliative (P) | 2019-05-15 | 2019-05-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100645077 |
| 20159060 | 20061015 | 1.59 | 80.5 | Adjuvant (A) | 2018-05-13 | 2018-05-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100124102 |
| 20159066 | 20061016 | 1.49 | 100 | Adjuvant (A) | 2017-08-09 | 2017-08-19 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100826118 |
| 20159067 | 20061017 | 1.7 | 83 | Curative (C) | 2017-02-17 | 2017-02-18 | ECX | N | null | ECX | 100737625 |
| 20159071 | 20061018 | 1.88 | 96 | Neo-adjuvant (N) | 2018-06-03 | 2018-06-04 | ECX | null | N | ECX | 101698248 |
| 20159074 | 20061019 | 1.64 | 59 | Palliative (P) | 2018-05-04 | 2018-05-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100790124 |
| 20159075 | 20061020 | 1.76 | 65 | Neo-adjuvant (N) | 2017-02-18 | 2017-02-18 | ECX | N | N | ECX | 100762941 |
| 20159078 | 20061021 | 1.79 | 90 | Curative (C) | 2019-03-03 | 2019-03-04 | ECX | 2 | N | ECX | 100307643 |
| 20159081 | 20061022 | 1.79 | 85.1 | Neo-adjuvant (N) | null | 2019-08-08 | ECX | null | N | ECX | 101446569 |
| 20159082 | 20061023 | 1.66 | 67.3 | Neo-adjuvant (N) | 2019-10-23 | 2019-11-03 | ECX | 02 | N | ECX | 101627115 |
| 20159083 | 20061024 | 1.47 | 64 | Palliative (P) | 2018-10-29 | 2018-11-11 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101335147 |
| 20159085 | 20061025 | 1.75 | 58.2 | null | 2019-07-27 | 2019-07-28 | Gemcitabine + Capecitabine | N | null | ECX | 101378536 |
| 20159086 | 20061026 | 1.74 | 99.5 | Neo-adjuvant (N) | null | 2016-08-11 | ECX | null | N | ECX | 100220513 |
| 20159087 | 20061027 | 1.61 | 88.4 | Neo-adjuvant (N) | 2016-06-03 | 2016-06-15 | ECX | 2 | N | ECX | 101768167 |
| 20159088 | 20061028 | 1.63 | 63.8 | Neo-adjuvant (N) | 2018-03-30 | 2018-03-30 | ECX | 2 | N | ECX | 100788625 |